InvestorsHub Logo
Followers 42
Posts 8466
Boards Moderated 2
Alias Born 11/14/2019

Re: None

Friday, 10/14/2022 11:57:37 AM

Friday, October 14, 2022 11:57:37 AM

Post# of 20431
I guess I will try again , let's use 3CL Pharma as an example.

TOMDF, the stock, owns 52% of 3CL for now.

We should own all of it because it is our IP and r&d

The BOD giveTollovid/r and tollotest IP and rights to a newco 3CL and retain only 52 % for shareholders and this seems okay to you....did the executive go along with that deal for their cut too???

So 3CL goes public

Do the Executive and BOD own some besides the 52% ? How much ? Salaried or new shares in Newco ?

So then another part of the company spins off ...TOMDF owned 100% but post spinoff that drops to 52%.......do the BOD and exec still only hold 52% or do they get a "job" in the newco....how are NET profits shared in the Newco

GC says no reverse split...oops had to do it sorry Bod and big investors insisted....anyone see the pattern here....what happens to TOMDF shareholders, do we get a fair cut in Newco, or 52%....but didn't we just have 100%, yes but "don't worry"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOMDF News